ORANGE PEEL NO MORE!

Dr Arturo Almeida explains the science behind cellulite... and how to treat it

Cellulite, more properly called gynoid lipodystrophy, remains one of the most daunting and intolerable aesthetic concerns for women. It most commonly occurs on the buttocks and thighs and is characterised by dimpled or lumpy skin, often resembling “orange peel” or cottage cheese-like dimpling of the skin. Cellulite can also appear on the abdomen, hips, and other areas of the body, and its formation accelerates during adolescence, pregnancy or in women around the menopausal age. It is more prevalent in females, affecting up to 85% of women over 20 years of age, and it’s rarely seen in men.

Although considered for many years an “invented disease”, it is now widely accepted that cellulite’s aetiology is multifactorial if unclear. However, it is known to incorporate environmental, hormonal, and genetic factors. Recent studies have prompted a search for underlying causes in the microvasculature and metabolic processes of the subcutaneous tissue.

Because cellulite is so impactful in women, coupled with the relentless quest for perfection that characterises our modern society, several treatments have emerged as temporary solutions. From the soothing strokes of massage therapists to topical creams, carboxytherapy, laser therapy, radiofrequency, and acoustic wave therapy, many explore these options with the hope of attaining a momentary respite from the grip of cellulite.

However, the truth remains that these treatments, while offering temporary relief, often fall short of providing lasting results. The elusive nature of cellulite and its intricate interplay with genetics and lifestyle renders it a formidable adversary. The very treatments designed to address it are often a testament to the resilience of this aesthetic nemesis.

ALIDYA: A PROVEN PIONEER IN CELLULITE TREATMENT WITH OVER A DECADE OF EXCELLENCE

In the dynamic landscape of aesthetic medicine, Alidya occupies a distinguished position as the first injectable class III medical device engineered exclusively for cellulite treatment. This unique approach positions Alidya as a ground-breaking innovation in cellulite management and a paradigm shift in the approach to this multifactorial cosmetic concern.

Alidya is the result of intense research in the field of cellulite performed by Professor Pasquale Motolese, an Italian plastic surgeon and an innovator in the field of aesthetic medicine, who identified the deposit of toxic heavy metals in the extracellular matrix secondary to the alteration of the microcirculation at the dermis level was a major contribute of cellulite.

Unlike generic solutions that offer a one-size-fits-all approach, Alidya presents a standard formulation with replicable results, engendering a sense of trust and reliability among practitioners and patients alike. Also, what sets Alidya apart is its remarkable track record spanning 11 years in the market, with scientific data and ongoing research proving its efficacy, safety, and lack of potentially serious side effects.

Alidya exemplifies a model of safety and therapeutic efficacy. Currently present in more than 50 countries, it is finally, available for UK practitioners. Embrace the future of cellulite treatment with Alidya—a union of innovation and aspiration with a proven track record of over a decade of excellence.